Thalidomide and dexamethasone as salvage therapy for refractory and relapsed myeloma.

被引：0
|
作者：
Palumbo, A [1 ]
Giaccone, L [1 ]
Bertola, A [1 ]
Bringhen, S [1 ]
Rus, C [1 ]
Triolo, S [1 ]
Pileri, A [1 ]
Boccadoro, M [1 ]
机构：
[1] Univ Turin, Sezione Ematol, Dipartimento Oncol, Turin, Italy
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5004
引用
收藏
页码：292B / 292B
页数：1
相关论文
共 50 条
  • [41] Salvage therapy with pegylated liposomal doxorubicin, bortezomib, cyclophosphamide, and dexamethasone in relapsed/refractory myeloma patients
    Romano, Alessandra
    Chiarenza, Annalisa
    Conticello, Concetta
    Cavalli, Maide
    Vetro, Calogero
    Di Raimondo, Cosimo
    Cunsolo, Rosario
    Palumbo, Giuseppe Alberto
    Di Raimondo, Francesco
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2014, 93 (03) : 207 - 213
  • [42] Primary therapy with thalidomide and dexamethasone in preparation to autologous transplantation for multiple myeloma.
    Cavo, M
    Zamagni, E
    Tosi, P
    Cellini, C
    de Vivo, A
    Cangini, D
    Tonelli, M
    Testoni, N
    Grafone, T
    Tacchetti, P
    Soverini, S
    Terragna, C
    Tura, S
    Baccarani, M
    BLOOD, 2003, 102 (11) : 448A - 448A
  • [43] Venetoclax salvage therapy in relapsed/refractory multiple myeloma
    Steinhardt, M.
    Truger, M.
    Bittrich, M.
    Zhou, X.
    Noderer, J.
    Riedhammer, C.
    Xiao, X.
    Gawlas, S.
    Philipp, W.
    Eisele, F.
    Haferlach, C.
    Mersi, J.
    Waldschmidt, J.
    Einsele, H.
    Rasche, L.
    Kortuem, K. M.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 58 - 58
  • [44] Venetoclax salvage therapy in relapsed/refractory multiple myeloma
    Steinhardt, Maximilian J.
    Truger, Marietta
    Bittrich, Max
    Zhou, Xiang
    Noderer, Julia
    Riedhammer, Christine
    Xiao, Xianghui
    Gawlas, Sophia
    Weis, Philipp
    Eisele, Florian
    Haferlach, Claudia
    Mersi, Julia
    Waldschmidt, Johannes
    Einsele, Hermann
    Rasche, Leo
    Kortuem, K. Martin
    HAEMATOLOGICA, 2024, 109 (03) : 979 - 981
  • [45] Thalidomide and dexamethasone in newly diagnosed multiple myeloma.
    McHugh, Johnny
    O'Ceallaigh, Cathal
    Keane, Colm
    Otridge, Brian W.
    O'Gorman, Peter
    BLOOD, 2006, 108 (11) : 370B - 370B
  • [46] Thalidomide and dexamethasone in newly diagnosed multiple myeloma.
    McHugh, J
    Keane, C
    Otridge, BW
    Thornton, P
    O'Gorman, P
    BLOOD, 2005, 106 (11) : 380B - 380B
  • [47] Vorinostat, Bortezomib, Cyclophosphomide, Thalidomide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients
    Gleason, Charise
    Kaufman, Jonathan L.
    Nooka, Ajay K.
    Valla, Kelly
    Heffner, Leonard T.
    Bisht, Aditya Singh
    Manubolu, Sanjay
    Watson, Melanie
    Boise, Lawrence H.
    Lonial, Sagar
    BLOOD, 2014, 124 (21)
  • [48] Combination of bortezomib, thalidomide, and dexamethasone in the treatment of relapsed, refractory IgD multiple myeloma
    Schmielau, J
    Teschendorf, C
    König, M
    Schmiegel, W
    Graeven, U
    LEUKEMIA & LYMPHOMA, 2005, 46 (04) : 567 - 569
  • [49] Bortezomib, dexamethasone and concomitant or sequential thalidomide (VTD): An effective combination for relapsed/refractory multiple myeloma failing thalidomide and dexamethasone
    Ozdemir, Evren
    Koc, Yener
    Kars, Ayse
    Turker, Alev
    Tekuzman, Gulten
    Kansu, Emin
    BLOOD, 2007, 110 (11) : 276B - 276B
  • [50] Clinical study of fludarabine, mitoxantrone, and dexamethasone in the treatment of refractory or relapsed multiple myeloma.
    Luo, SK
    Li, J
    Hong, WD
    Zhao, Y
    Tong, XZ
    BLOOD, 2005, 106 (11) : 380B - 380B
12345